The recent Medical-Tech-SaaS IPO
had some problems in their S-1 report. I expect it to sink to "below ipo
level" as the problems could show up in 1-2 quaters after IPO
The problem is called "Medicity buyout" and hiding the price of acquision besides the main datasheet in S-1.
Second problem is that it has very slow growth.